What are the side effects of formoterol (long-acting beta2-adrenergic receptor agonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Formoterol (Long-Acting Beta2-Adrenergic Receptor Agonist)

Formoterol can cause several side effects ranging from mild to serious, with the most concerning being an increased risk of asthma-related death when used as monotherapy in asthma patients. 1

Common Side Effects

  • Cardiovascular effects:

    • Palpitations and tachycardia 1
    • Increased risk of cardiovascular events (2.7% vs 0.7% with placebo) 2
    • Chest pain (1.9% vs 1.3% with placebo) 1
  • Neurological effects:

    • Tremor (1.9% vs 0.4% with placebo) - dose-related 1
    • Dizziness (1.6% vs 1.5% with placebo) - dose-related 1
    • Headache 3
    • Insomnia (1.5% vs 0.8% with placebo) 1
  • Metabolic effects:

    • Reduced serum potassium (hypokalemia) 2, 3
    • Hyperglycemia 1
    • Metabolic acidosis 1
  • Respiratory effects:

    • Viral infections (17.2% vs 17.1% with placebo) 1
    • Bronchitis (4.6% vs 4.3% with placebo) 1
    • Chest infection (2.7% vs 0.4% with placebo) 1
    • Dyspnea (2.1% vs 1.7% with placebo) 1
    • Dysphonia (1.0% vs 0.9% with placebo) - dose-related 1
  • Other effects:

    • Dry mouth 1
    • Muscle cramps 1
    • Rash (1.1% vs 0.7% with placebo) 1

Serious Side Effects

  • Asthma-related adverse events:

    • Increased risk of asthma-related death (FDA black box warning) 1
    • Serious asthma exacerbations requiring hospitalization (0.6% with 12 mcg twice daily vs 0.2% with placebo) 1
    • Higher risk of severe exacerbations with higher doses (24 mcg twice daily) 1
  • Severe cardiovascular effects:

    • Angina 1
    • Hypertension or hypotension 1
    • Arrhythmias 1
    • Increased risk of atrial fibrillation, particularly in patients with COPD or asthma and structural heart disease 2
  • Rare but serious reactions:

    • Anaphylactic reactions including severe hypotension and angioedema 1

Special Considerations

Risk Factors for Adverse Effects

  • Pre-existing cardiac conditions:

    • Patients with pre-existing cardiac arrhythmias and hypoxemia are at higher risk for cardiac adverse effects 4
    • Higher doses (24 mcg) show more cardiac effects than lower doses (12 mcg) 4
  • Age and disease state:

    • Children with asthma may experience different adverse event patterns, with more infections/inflammation and abdominal complaints 1
    • COPD patients may have different side effect profiles than asthma patients 1

Tachyphylaxis

  • Tachyphylaxis (reduced response over time) to the bronchoprotective effect occurs with regular use 2, 3
  • Tachyphylaxis to the bronchodilator effect is more likely with formoterol (full agonist) than with salmeterol (partial agonist) 3

Important Warnings and Precautions

  • Never use formoterol as monotherapy for asthma - it should always be used in combination with inhaled corticosteroids 2
  • The FDA has added warnings about the safety of long-acting beta agonists due to increased risk of severe exacerbations and deaths 2
  • Higher doses are associated with greater risk of serious adverse events 1
  • Regular monitoring is recommended, especially in patients with cardiovascular risk factors 4
  • Formoterol may mask worsening of underlying inflammatory conditions due to its potent bronchodilatory effects 2

By understanding these side effects and following appropriate precautions, healthcare providers can better manage patients requiring formoterol therapy while minimizing risks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse effects of beta-agonists: are they clinically relevant?

American journal of respiratory medicine : drugs, devices, and other interventions, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.